• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Altius Minerals Corp
Altus Power, Inc. Class A Common Stock
Autonomix Medical, Inc. - Common Stock
BitVentures Limited - Ordinary Share
Blue Moon Metals Inc
Chesapeake Gold Corp
Clarus Therapeutics Holdings, Inc. - Common Stock
Clear Blue Technologies Intl Inc
Dime Community Bancshares, Inc. - Common Stock
Direxion Daily PANW Bull 2X ETF
Espial Group Inc
Gensource Potash Corp Ord
Glenstar Minerals Inc
Hong Kong Hang Seng
Kandal M Venture Limited - Class A ordinary Shares
LifeStance Health Group, Inc. - Common Stock
Lode Gold Resources Inc
Medbright AI Invts Inc
Mobile-health Network Solutions - Class A Ordinary Shares
PAMT CORP - Common Stock
PDC Energy, Inc. - Common Stock
Piedmont Lithium Inc. - Common Stock
Preformed Line Products Company - Common Stock
Raadr Inc
Republic Technologies Inc
Tudor Gold Corp New
US Nuclear Corp
Veradigm Inc. - common stock
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fennec Pharmaceuticals Inc. - Common Stock (NQ:FENC)

10.69 +0.42 (+4.09%)
Delayed Quote Updated: 10:47 AM EDT, Oct 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,841
Open 10.12
Bid (Size) 10.62 (100)
Ask (Size) 10.75 (200)
Prev. Close 10.27
Today's Range 10.12 - 10.73
52wk Range 5.650 - 13.25
Shares Outstanding 28,062,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Adherex Technologies Q2 Earnings Call Highlights ↗
August 11, 2026
Adherex Technologies (NASDAQ:FENC), operating as Fennec Pharmaceuticals, reported second-quarter 2026 net product sales of $17.1 million, up approximately 78% from $9.7 million in the prior-year... 
Via MarketBeat
Topics Earnings
News headline image
Adherex Technologies’ PEDMARK Push Targets Larger AYA Market After Record Quarter ↗
May 23, 2026
Fennec Pharmaceuticals (NASDAQ:FENC) executives outlined the company’s commercial strategy for PEDMARK, its sodium thiosulfate product used to prevent cisplatin-related hearing loss, during a fireside... 
Via MarketBeat
Topics Intellectual Property

Performance

52-Week Range 19.3% below 52-week high
10.69
5.6552W Low 13.2552W High
1 Week 0.6% below 1-week high
9.871W Low 10.751W High

Fennec Pharmaceuticals Inc. - Common Stock (FENC) traded between $5.65 and $13.25 over the past 52 weeks and last traded at $10.69, 19.3% below its 52-week high. Over the past week it ranged between $9.87 and $10.75.

Past 12 Months
+5.0%
-2.0%
+8.0%
+58.8%
+39.2%
+23.4%
1W +$0.51
1M -$0.22
3M +$0.79
6M +$3.96
YTD +$3.01
1Y +$2.03

FENC was +23.4% over the past year, +58.8% over six months, +39.2% year to date, +5.0% in the last week.

12 Months vs Market
FENC
+23.4%
DIA
+12.6%
SPY
+14.9%
QQQ
+17.9%
IWM
+11.3%

Over the past 12 months FENC returned +23.4% versus DIA (Dow) +12.6%, SPY (S&P 500) +14.9%, QQQ (Nasdaq 100) +17.9% and IWM (Russell 2000) +11.3%.

Volume & Liquidity 0.07× 3-mo avg
Today 13,841 3-mo avg 187.6K
1W
157.0K
1M
129.6K
3M
187.6K
6M
227.7K
YTD
203.5K
1Y
195.1K

FENC most recently traded 13,841 shares against a 3-month average daily volume of 187.6K.

More News

Read More
News headline image
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 18, 2026
From Fennec Pharmaceuticals Inc.
Via GlobeNewswire
Fennec Pharmaceuticals (NASDAQ:FENC) Q1 Beat Overshadowed by Surging Costs ↗
May 14, 2026
Via Chartmill
Fennec Pharmaceuticals (NASDAQ:FENC) Reports Q4 2025 Revenue Growth but Misses Earnings Estimates ↗
March 24, 2026
Via Chartmill
News headline image
Earnings Scheduled For August 14, 2025 ↗
August 14, 2025
Via Benzinga
News headline image
Fennec Pharmaceuticals Earnings Preview ↗
August 13, 2025
Via Benzinga
These stocks are moving in today's session ↗
May 14, 2026
Via Chartmill
News headline image
Fennec (FENC) Q1 2026 Earnings Call Transcript ↗
May 14, 2026
Via The Motley Fool
Topics Earnings
News headline image
Adherex Technologies Q1 Earnings Call Highlights ↗
May 14, 2026
Via MarketBeat
Topics Earnings
News headline image
Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026
From Fennec Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026
May 07, 2026
From Fennec Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting
April 21, 2026
From Fennec Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Water Giant With $7 Billion in Revenue Draws $7.5 Million Investment, and Shares Are Surging This Year ↗
March 15, 2026
Via The Motley Fool
News headline image
Payments Stock Down 30% Draws $6 Million Bet as Company Posts $4 Billion in Revenue ↗
March 15, 2026
Via The Motley Fool
News headline image
Solas Capital Loads Up On Kyndryl With 407,000 Shares Bought ↗
March 05, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Fennec Q2 Sales Jump 33 Percent ↗
August 14, 2025
Via The Motley Fool
News headline image
Fennec (FENC) Q2 2025 Earnings Call Transcript ↗
August 14, 2025
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Reports Mixed Q2 2025 Earnings with Revenue Slight Miss and Wider-Than-Expected Loss ↗
August 14, 2025
Via Chartmill
News headline image
Earnings Scheduled For May 13, 2025 ↗
May 13, 2025
Via Benzinga
News headline image
Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday? ↗
March 10, 2025
Via Benzinga
Topics Economy Stocks
News headline image
Earnings Scheduled For March 10, 2025 ↗
March 10, 2025
Via Benzinga
News headline image
Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗
February 10, 2025
Via Benzinga
News headline image
FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 ↗
August 13, 2024
Via InvestorPlace
News headline image
3 Dirt-Cheap Stocks Under $10 That Could EXPLODE! ↗
July 29, 2024
Via InvestorPlace

Frequently Asked Questions

Is Fennec Pharmaceuticals Inc. - Common Stock publicly traded?
Yes, Fennec Pharmaceuticals Inc. - Common Stock is publicly traded.
What exchange does Fennec Pharmaceuticals Inc. - Common Stock trade on?
Fennec Pharmaceuticals Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Fennec Pharmaceuticals Inc. - Common Stock?
The ticker symbol for Fennec Pharmaceuticals Inc. - Common Stock is FENC on the Nasdaq Stock Market
What is the current price of Fennec Pharmaceuticals Inc. - Common Stock?
The current price of Fennec Pharmaceuticals Inc. - Common Stock is 10.69
When was Fennec Pharmaceuticals Inc. - Common Stock last traded?
The last trade of Fennec Pharmaceuticals Inc. - Common Stock was at 10/20/26 10:47 AM ET
What is the market capitalization of Fennec Pharmaceuticals Inc. - Common Stock?
The market capitalization of Fennec Pharmaceuticals Inc. - Common Stock is 299.98M
How many shares of Fennec Pharmaceuticals Inc. - Common Stock are outstanding?
Fennec Pharmaceuticals Inc. - Common Stock has 300M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap